Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Aug 30.
Published in final edited form as: Xenotransplantation. 2019 Apr 1;26(4):e12511. doi: 10.1111/xen.12511

The ‘Baby Fae’ baboon heart transplant – potential cause of rejection

David KC Cooper 1, Hidetaka Hara 1, C Adam Banks 1, David Cleveland 1, Hayato Iwase 1
PMCID: PMC6717028  NIHMSID: NIHMS1043616  PMID: 30932224

Dear Sir,

In their very thoughtful commentary discussing our paper on the possibility of achieving immunological tolerance to pig heart xenografts in neonates,1 Jeffrey Platt and his coauthors2 discuss the well-known transplant of a baboon heart into the patient known as Baby Fae in 1984 by Loma Linda surgeon, Leonard Bailey.3 Despite ABO-incompatibility between patient and graft, the baboon heart functioned well for two weeks, but then underwent rejection, the baby sadly dying on day 20.

In the light of extensive more recent experience by Lori West and her colleagues,4,5 Platt et al do not believe that blood group incompatibility was a major factor in failure of the graft, a conclusion with which we agree. Many years ago, studies of heart transplantation between closely-related nonhuman primate species demonstrated that, although ABO-incompatibility had some detrimental effect, the species discrepancy appeared to be more important.6,7

However, Platt et al. go on to state that “none of the saccharide antigens thought to impair transplantation of hearts from pigs into humans should have been pertinent to the fate of the transplant in Baby Fae.” With this point, we respectfully disagree.

We suggest that a major factor might have been the fact that baboon organs express N-glycolylneuraminic acid (Neu5Gc) (as do all Old World nonhuman primates, including chimpanzees and gorillas), but human organs do not.8,9 Humans therefore make anti-Neu5Gc antibodies, which can be detected in almost all human sera,10 and can increase in activity after exposure to the carbohydrate. Indeed, after galactose-α1,3-galactose (Gal), Neu5Gc appears to be the next most important target for human anti-pig antibodies (though in Old World monkeys Sda would appear more important).11 The blood transfusions that Baby Fae received might have increased the anti-Neu5Gc antibody titers.

It is very likely that antibodies directed against Neu5Gc also played a role in the outcome of the clinical chimpanzee kidney transplants carried out by Keith Reemtsma in 196412 and of the other transplants in which nonhuman primate organs were transplanted into patients13.

We suggest that the presence of antibodies to Neu5Gc in Baby Fae’s blood might well account for rejection of the baboon heart graft.

References

  • 1.Cooper DKC, Hara H, Iwase H, Banks CA, Cleveland D. An approach to induction of tolerance to pig cardiac xenografts in neonates. Xenotransplantation. 2018; 25(6):e12454. Doi: 10.1111/xen.12454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Platt JL, West LJ, Chinnock RE, Cascalho M. Toward a solution for cardiac failure in the newborn. Xenotransplantation 2018;25(6):e12479. doi: 10.1111/xen12479.Epub2018Dec11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bailey LL, Nehlsen-Cannarella SL, Concepcion W, Jolley WB. Baboon-to-human cardiac xenotransplantation in a neonate. J Am Med Assoc. 1985;254:3321–3329. [PubMed] [Google Scholar]
  • 4.West LJ, Pollock-Barziv SM, Dipchand AI, et al. ABO-incompatible heart transplantation in infants. N Engl J Med. 2001;344:793–800. [DOI] [PubMed] [Google Scholar]
  • 5.Urschel S, West LJ. ABO-incompatible heart transplantation. Curr Opin Pediatr. 2016;28:613–619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cooper DKC, Human PA, Rose AG, et al. The role of ABO blood group compatibility in heart transplantation between closely related animal species. An experimental study using the vervet monkey to baboon cardiac xenograft model. J Thorac Cardiovasc Surg. 1989;97:447–455. [PubMed] [Google Scholar]
  • 7.Cooper DKC. Allo- and xeno- transplantation in non-human primates. Minerva Chirurgica 1991;46 [Suppl. 1 al N. 11]:107–116. [Google Scholar]
  • 8.Varki A Colloquium paper: uniquely human evolution of sialic acid genetics and biology. Proc Natl Acad Sci USA. 2010;11:8939–8946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Padler-Karavani V, Varki A. Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation 2011;18:1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gao B, Long C, Lee W, et al. Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans. PLoS One. 2017;12(7):e0180768. doi: 10.1371/journal.pone.0180768.eCollection2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Li Q, Shaikh S, Iwase H, et al. Carbohydrate antigen expression and anti-pig antibodies in New World capuchin monkeys: relevance to studies of xenotransplantation. Xenotransplantation. 2019;e12498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Reemtsma K, McCracken BH, Schlegel JU, et al. Renal heterotransplantation in man. Ann Surg. 1964;160:383–410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Taniguchi S, Cooper DKC. Clinical xenotransplantation: past, present and future. Ann R Coll Surg Engl 1997;79:13–19. [PMC free article] [PubMed] [Google Scholar]

RESOURCES